The purpose of this study is to evaluate the effect of "combined probiotics" to improve the gastrointestinal function and intestinal bacteria flora
Probiotics were known to improve gastrointestinal function before. This is a single-blind placebo control clinical study. We will perform gastrointestinal function questionnaire and collect stool as baseline data before the study (0-week). Then healthy subjects will be randomized to two groups. Experimental: probiotics 1 pack bid for 3 weeks. Probiotics : (AB-kefir):Lactobacillus acidophilus,Bifidobacterium longum,Lactobacillus paracasei,Lactobacillus rhamnosus,Lactobacillus fermentum,Streptococcus thermophilus,Lactobacillus helveticus,Kluyveromyces fragilis. Other components include starch,oligosaccharide,yeast powder, superior standard spice, calcium pantothenate, VitB1, VitB12, biotin and folic acid. Placebo group: placebo 1 pack bid for 3 weeks. Placebo: Except the probiotics (AB-kefir),the other components are the same with study group. Then gastrointestinal function questionnaire and stool collection will be performed at the end of 1st, 2nd, 3rd, and 4th weeks after starting the study.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
48
probiotics 1 pack (2g) bid for three weeks
National Cheng Kung University Hospital
Tainan, Taiwan
Changes of gastrointestinal function after probiotics use
Changes of gastrointestinal function, such as constipation, abdominal distension and appetite after proiotics and placebo use.
Time frame: 28 days
Changes of intestinal bacteria flora after probiotics use
1. Changes of intestinal bacteria flora: (1) aerobic bacteria count (2) anaerobic bacteria count (3) Bifidobacterium count (4) Clostridium perfringens count (5) Staphylococcus aureus count (6) E. coli and K. pneumoniae count 2. The ratio for the antibiotics resistant bacteria ( such as Vancomycin-resistant Enterococcus,third-generation cephalosporin resistance E. coli, Methicillin-resistant Staphylococcus aureous, Extended-spectrum beta lactamase E. coli and K. pneumoniae) 3. Changes of the bacteria virulence factors for the intestinal E. coli and K. pneumonia
Time frame: 28 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.